Sana Biotechnology, Inc. has placed 23 500 000 shares in an IPO priced $25 per share, which is $1 above the upper limit of the previously announced range ($23-24). Besides, Santa has granted the underwriters a 30-day option to purchase up to 3 525 000 shares at the public offering price.
The trading debut will take place on the Nasdaq Global Select Market on February 4,2021 under the ticker symbol “SANA”.